Company / Working Capital
IONIS PHARMACEUTICALS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$2.2B
FY2025
5-year range
$1.9B / $2.3B
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#18 of 213
Health Care
What the data says
Among 213 Health Care companies, IONIS PHARMACEUTICALS INC is in the top 8% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $664M in FY2016 to $2.4B in FY2019.
Based on SEC 10-K filings.
$2.2B in FY2025 with a 5-year CAGR of +7.4%. Top quartile in the Health Care sector.
Remained stable around $2.2B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 213This company $2.2B Sector average $934.6M
▼
+136.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.4%, indicating consistent growth.
- In FY2025, working capital decreased 4.4% year-over-year.
- Ranks #18 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | -4.4% |
| FY2024 | $2.3B | +5.3% |
| FY2023 | $2.2B | +16.0% |
| FY2022 | $1.9B | -10.1% |
| FY2021 | $2.1B | +36.0% |
| FY2020 | $1.5B | -36.8% |
| FY2019 | $2.4B | +27.0% |
| FY2018 | $1.9B | +108.4% |
| FY2017 | $925.1M | +39.3% |
| FY2016 | $664.1M | -3.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026